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Abstract
Background: Congenital alveolar rhabdomyosarcoma is an extremely uncommon and invariably
fatal tumor with the current therapy. Less than 25% of patients present with evidence of cutaneous
metastasis.
Case presentation: We report a case of congenital alveolar rhabdomyosarcoma in an 18-month-
old male who presented with a progressively increasing mass lesion in the left post-auricular region
since birth. Radiological examination did not show any intracranial involvement of the mass lesion.
Upon resecting the mass that was 10-cm in largest dimension, the gross, microscopic, and
ultrastructural findings were consistent with congenital alveolar rhabdomyosarcoma.
Conclusion: The suspicion of alveolar subtype on histological grounds and proper evaluation of
this tumor by immunostain and ultrastuctural examination is necessary. In the Medline literature
search, there is no report of large congenital alveolar rhabdomyosarcoma in the post-auricle
region.
Background
Although rhabdomyosarcoma (RMS) is an uncommon
childhood malignancy, it is the most frequently encoun-
tered soft tissue sarcoma found in infants and children
[1]. Six percent of all RMS cases occur in children age <1
year at the time of diagnosis [2,3]. RMS is slightly more
common in males than females (range, 1.3–1.4: 1). The
head and neck, extremities, genitourinary tract, and trunk
are the most common primary sites. Overall, < 25% of
patients have metastatic spread at the time of diagnosis,
with the most common sites including the lung, lymph
nodes, bone, and bone marrow.
Congenital alveolar RMS, defined as disease present at
birth, is a rare subtype of RMS. We present a case of con-
genital alveolar RMS, which was completely resected at
the age of 18 months.
Case report
An eighteen-month-old male child presented with a mass
lesion in the left post-auricle region. The mass was present
at birth and was gradually increasing in size. The measure-
ment of the mass was 10 × 6 × 4 cm. The skin over it was
unremarkable, and the other systemic examination was
within normal limits. A non-contrast computed tomogra-
phy of head and neck revealed the mass in the left post-
auricular region (Figure 1). There was no intracranial
involvement.
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osarcoma (RMS) was made after complete excision of the
mass. Grossly, the mass was fairly well circumscribed,
multinodular with a glistening, gelatinous gray-white sur-
face. Cystic areas were seen in between (Figure 2). Neither
haemorrhage nor necrosis was present.
Microscopically, it revealed a varying degree of cellularity
with densely packed cellular areas separated by a frame-
work of hyalinized fibrous septa. The tumor cells were dis-
cohesive in the centre. The individual cells were large,
round with darkly staining hyperchromatic nuclei, incon-
spicuous nucleoli, and scant indistinct cytoplasm (Figure
3). High mitotic rate was noticed. The tumor cells (≈40%)
were positive for desmin and myogenin (Figure 4) immu-
nostains. The other panels of immunostains used were
CD45, CD20, MIC-2, CK, Neuron specific enolase, and
myeloperoxidase, all of which were negative.
Ultrastructuraly, the tumor cells showed few cytoplasmic
organelles and occasional bundles of thin myofilaments
measuring 4–6 nm in diameter. Bone marrow examina-
tion didn't reveal any metastatic deposit. A cytogenetic
analysis was not performed because of technical reasons.
In the one year follow-up period, there has been no recur-
rence or metastatic deposit.
Discussion
Rhabdomyosarcoma (RMS), a malignant tumor originat-
ing from skeletal muscle, usually occurs in the first two
decades of life. The vast majority of RMS occurs in head
and neck region, extremities, genitourinary system and
trunk. RMS bears a close resemblance to various stages in
the embryogenesis of normal skeletal muscle, but its pat-
tern is much more variable and ranges from poorly differ-
entiated tumours that are very difficult to diagnose
without immunohistochemical or electron microscopic
examination to a well-differentiated RMS.
Non-contrast computed tomography of head showing the hypoechoeic mass without any intracranial extensionFigure 1
Non-contrast computed tomography of head showing the hypoechoeic mass without any intracranial extension.Page 2 of 5
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in the neonatal period to be 7.2 per 100,000 live births
per year (1:13,700) [3]. In the same study, soft tissue
tumours represented 17% of all tumours presenting
within the first month of life; however, the majority of
these tumours (65%) were histologicaly benign [6]. Over-
all, <1% of all patients with RMS present with the disease
within the first month of life and in these cases the histol-
ogy predominantly is of the embryonal sub-type [3-6].
Alveolar RMS is characterized by specific chromosomal
translocations, the majority of which are the
t(2;13)(q35;q14) translocation.
Only a few cases (less than 20) have been reported in the
literature about alveolar subtype of congenital rhabdomy-
osarcoma. Alveolar RMS has been previously described in
the region of the eyes, ears, infratemporal, cervical and
parameningeal regions in neonates and children [7]. But
to the best of our knowledge, there has been no record of
congenital alveolar RMS in the post-auricle region.
Our case belongs to Group II of clinical staging (Inter-
group Rhabdomyosarcoma Studies Classification) [8].
The alveolar type, large size (>5 cm) and location are poor
prognostic factors in our case. Morphologically, 'solid'
forms of alveolar RMS can also be seen which might sim-
ulate the round cell areas of embryonal RMS. However,
uniform cellular pattern, multinucleate giant cells and
incipient alveolar features, supported by cytogenetic stud-
ies help in differentiating between the two. All the mor-
phological features mentioned above were seen in our
case. It is important not to confuse the two, as the alveolar
type carries a less favourable prognosis.
Differential diagnosis includes neuroblastoma, neuroepi-
thelioma, extra skeletal Ewing's sarcoma, melanotic neur-
oectodermal tumour of infancy and malignant
lymphoma.
The clinical management of neonates with malignancy
presents considerable problems due to the physiologic
immaturity of many organ systems in infants. Neonates in
the Intergroup Rhabdomyosarcoma Studies Classification
(IRS) study received 70% of the prescribed dose of the
three principal agents used to treat RMS (cyclophospha-
mide, vincristine, and actinomycin D). Severe myelosup-
pression and infections were the principal side effects. It is
interesting to note that our patient had no recurrence of
the lesion or any metastatic deposit elsewhere at the end
of one year follow-up. Surgery followed by the standard
chemotherapy regimen was given according to the treat-
ment plan. Grundy et al reported the longest survivor who
Gross specimen revealing glistening gelatinous gray-white cut surface with cystic areasFigure 2
Gross specimen revealing glistening gelatinous gray-white cut surface with cystic areas.Page 3 of 5
(page number not for citation purposes)
Diagnostic Pathology 2006, 1:37 http://www.diagnosticpathology.org/content/1/1/37
Page 4 of 5
(page number not for citation purposes)
Photomicrograph showing nodules of tumor cells separated by hyalinised fibrous septae (50×, HE stain)Figure 3
Photomicrograph showing nodules of tumor cells separated by hyalinised fibrous septae (50×, HE stain). Inset: Discohesive 
large tumor cells with hyperchromatic nucleus and scant cytoplasm (200×, HE stain).
Myogenin immunostain revealing nuclear positivity (200×, immunoperoxidase)Figure 4
Myogenin immunostain revealing nuclear positivity (200×, immunoperoxidase).
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underwent myeloablative therapy with peripheral stem
cell support, and hence suggest that more intensive treat-
ment may be of value in this rare condition [9].
Conclusion
Our case exemplifies the rare sub-type of congenital RMS
occurring in the post-auricular area. This is a highly malig-
nant tumor with no record of long-term survivors. In this
setting, clinical outcome and radiological findings must
be accounted for by both pathologists and clinicians who
must be aware of such an unusual presentation of congen-
ital rhabdomyosarcoma, whose diagnosis requires repre-
sentative tissue sampling and whose treatment may
require an adjustment of drug dosage.
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